US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Adlai Nortye Biopharma Co. Ltd.

15.28

+0.58503.98%

Volume:64.49K

Turnover:985.61K

Market Cap:984.00M

PE:-27.05

High:15.56

Open:14.97

Low:14.70

Close:14.70

52wk High:17.25

52wk Low:0.8786

Shares:64.40M

Float Shares:45.14M

Volume Ratio:0.55

T/O Rate:0.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5649

EPS(LYR):-1.1111

ROE:-20.23%

ROA:-8.70%

PB:4.58

PE(LYR):-13.75

Loading ...

Overview Company News Filings

Adlai Nortye Doses First Patient in Phase I Trial for Solid Tumors

MT Newswires Live

Adlai Nortye doses first patient in AN4035 trial

Adlai Nortye Wins FDA IND Clearance for An4035 ADC Trial Expansion to US

Adlai Nortye Group - to File Ind Application for An4035 with China Nmpa

THOMSON REUTERS

Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA Ind Clearance for An4035, a First-in-Class Pan-Ras(on) Inhibitor-Based ADC

THOMSON REUTERS

Adlai Nortye assumed with a Buy at Lucid Capital

Adlai Nortye's KRAS Opportunity Further Validated by GSK-Hutchmed Deal, Oppenheimer Says

MT Newswires Live

Oppenheimer Sticks to Their Buy Rating for Adlai Nortye Ltd. Sponsored ADR (ANL)

Major Insider Move Shakes Up Adlai Nortye’s Market Narrative

Adlai Nortye Calls September Extraordinary Meeting to Authorize Major Share Issuance and Board Changes

Prince Harry, Elton John and other celebrities hit with initial $13 million bill after losing case against UK tabloid

Analysts’ Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (ANL)

Earnings Flash (ANL) Adlai Nortye Posts H1 Revenue $13.1M

MT Newswires Live

Adlai Nortye FY26 H1 Net Loss Narrows 70.9% to Us$5.3 Million; Revenue Turns to Us$13.1 Million

Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress

THOMSON REUTERS

Adlai Nortye Director Lars Erik Birgerson Files Initial Beneficial Ownership Statement

Adlai Nortye Receives Ethics Approval to Begin Phase 1 Trial of Cancer Drug AN4035

MT Newswires Live

Adlai Nortye - in Process of Ind Submissions for An4035 to U.S. FDA and China Nmpa

THOMSON REUTERS

Adlai Nortye Announces Clinical Trial Notification Submission and Hrec Approval for the Phase I Clinical Trial of Pan-Ras(on) Inhibitor ADC An4035 in Australia

THOMSON REUTERS

Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/ANL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANL\",,,,,undefined,":{"symbol":"ANL","market":"US","secType":"STK","nameCN":"Adlai Nortye Biopharma Co. Ltd.","latestPrice":15.28,"timestamp":1789060225669,"preClose":14.695,"halted":0,"volume":64488,"delay":0,"changeRate":0.03980945899965969,"floatShares":45135300,"shares":64397900,"eps":-0.564922,"marketStatus":"Trading","change":0.585,"latestTime":"09-10 13:10:57 EDT","open":14.97,"high":15.5625,"low":14.7,"amount":985610.73144,"amplitude":0.058693,"askPrice":15.35,"askSize":100,"bidPrice":15.15,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-0.564922,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"adrRate":3,"listingDate":1695960000000,"exchange":"NASDAQ","adjPreClose":14.695,"preHourTrading":{"tag":"盘前","latestPrice":14.91,"preClose":14.695,"latestTime":"08:56 EDT","volume":12,"amount":179.337192,"timestamp":1789045006214,"change":0.215,"changeRate":0.014631,"amplitude":0.004056},"postHourTrading":{"tag":"盘后","latestPrice":14.695,"preClose":14.695,"latestTime":"19:30 EDT","volume":10,"amount":146.95,"timestamp":1788996607102,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.552369},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANL\",,,,,undefined,":{"symbol":"ANL","floatShares":45135300,"roa":"-8.70%","roe":"-20.23%","lyrEps":-1.111136,"volumeRatio":0.552369,"shares":64397900,"dividePrice":0,"high":15.5625,"amplitude":0.058693,"preClose":14.695,"low":14.7,"week52Low":0.8786,"pbRate":"4.58","psRate":"54.50","week52High":17.25,"institutionHeld":0,"latestPrice":15.28,"committee":-0.666667,"eps":-0.564922,"divideRate":0,"volume":64488,"delay":0,"ttmEps":-0.564922,"open":14.97,"prevYearClose":1.42,"prevWeekClose":15.01,"prevMonthClose":14.19,"prevQuarterClose":11.5,"fiveDayClose":13.855,"twentyDayClose":13.09,"sixtyDayClose":11.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"ANL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2026-04-10","symbol":"ANL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1775793600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-04-30","symbol":"ANL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1782187200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANL","date":"2026-09-08","current":-26.012441,"percent":0.001406,"low":-43.048201,"twenty":-6.404178,"median":-1.664553,"eighty":-1.230744,"high":-0.626043,"avg":-4.572455,"sd":6.757799,"marketCap":966613034},"quantilePoints":[{"date":"2023-09-29","current":-21.000086,"twenty":-21.000086,"median":-21.000086,"eighty":-21.000086,"marketCap":2575618522},{"date":"2023-10-06","current":-3.305231,"twenty":-4.565236,"median":-3.850016,"eighty":-3.652189,"marketCap":405379951},{"date":"2023-10-13","current":-3.074047,"twenty":-3.986973,"median":-3.309218,"eighty":-3.232187,"marketCap":377025751},{"date":"2023-10-20","current":-2.876099,"twenty":-3.767842,"median":-3.305231,"eighty":-3.074023,"marketCap":352747747},{"date":"2023-10-27","current":-2.646285,"twenty":-3.700885,"median":-3.256535,"eighty":-2.976534,"marketCap":324561522},{"date":"2023-11-03","current":-2.38914,"twenty":-3.583595,"median":-3.136378,"eighty":-2.6037,"marketCap":293023261},{"date":"2023-11-10","current":-2.542294,"twenty":-3.309029,"median":-2.952186,"eighty":-2.545904,"marketCap":311807264},{"date":"2023-11-17","current":-2.953273,"twenty":-3.307665,"median":-2.895732,"eighty":-2.565761,"marketCap":362213030},{"date":"2023-11-24","current":-3.068804,"twenty":-3.305231,"median":-2.95273,"eighty":-2.587423,"marketCap":376382733},{"date":"2023-12-01","current":-3.309495,"twenty":-3.305231,"median":-3.065796,"eighty":-2.590191,"marketCap":405902948},{"date":"2023-12-08","current":-3.417806,"twenty":-3.308274,"median":-3.068804,"eighty":-2.593054,"marketCap":419187044},{"date":"2023-12-15","current":-2.861209,"twenty":-3.308274,"median":-3.068804,"eighty":-2.599458,"marketCap":350921548},{"date":"2023-12-22","current":-2.647596,"twenty":-3.305231,"median":-3.065796,"eighty":-2.599458,"marketCap":324722358},{"date":"2023-12-29","current":-2.578397,"twenty":-3.280459,"median":-3.01164,"eighty":-2.596896,"marketCap":316235296},{"date":"2024-01-05","current":-2.8582,"twenty":-3.262462,"median":-2.955379,"eighty":-2.605475,"marketCap":350552546},{"date":"2024-01-12","current":-2.825105,"twenty":-3.251665,"median":-2.915364,"eighty":-2.632892,"marketCap":346493516},{"date":"2024-01-19","current":-2.722812,"twenty":-3.232187,"median":-2.876099,"eighty":-2.646285,"marketCap":333947425},{"date":"2024-01-26","current":-2.771913,"twenty":-3.228262,"median":-2.846151,"eighty":-2.647596,"marketCap":339969549},{"date":"2024-02-02","current":-2.746851,"twenty":-3.225253,"median":-2.834101,"eighty":-2.678886,"marketCap":336895756},{"date":"2024-02-09","current":-2.665648,"twenty":-3.211684,"median":-2.808133,"eighty":-2.665648,"marketCap":326936374},{"date":"2024-02-16","current":-2.223379,"twenty":-3.198709,"median":-2.771913,"eighty":-2.599458,"marketCap":272692980},{"date":"2024-02-23","current":-2.139558,"twenty":-3.188655,"median":-2.771913,"eighty":-2.587423,"marketCap":262412565},{"date":"2024-03-01","current":-2.151172,"twenty":-3.179643,"median":-2.746851,"eighty":-2.53748,"marketCap":263836916},{"date":"2024-03-08","current":-2.33169,"twenty":-3.177296,"median":-2.746851,"eighty":-2.478771,"marketCap":285977077},{"date":"2024-03-15","current":-2.710777,"twenty":-3.131384,"median":-2.743872,"eighty":-2.478771,"marketCap":332471414},{"date":"2024-03-22","current":-2.737855,"twenty":-3.083228,"median":-2.737855,"eighty":-2.479113,"marketCap":335792438},{"date":"2024-03-28","current":-2.74989,"twenty":-3.073974,"median":-2.737855,"eighty":-2.49897,"marketCap":337268449},{"date":"2024-04-05","current":-3.026684,"twenty":-3.070853,"median":-2.740864,"eighty":-2.515818,"marketCap":371216696},{"date":"2024-04-12","current":-3.324538,"twenty":-3.142817,"median":-2.743872,"eighty":-2.515818,"marketCap":407747961},{"date":"2024-04-19","current":-3.204193,"twenty":-3.177476,"median":-2.746851,"eighty":-2.532666,"marketCap":392987854},{"date":"2024-04-26","current":-4.736082,"twenty":-3.207189,"median":-2.746851,"eighty":-2.553125,"marketCap":496677607},{"date":"2024-05-03","current":-4.581262,"twenty":-3.239041,"median":-2.748386,"eighty":-2.571177,"marketCap":480441489},{"date":"2024-05-10","current":-4.574224,"twenty":-3.298764,"median":-2.771913,"eighty":-2.583813,"marketCap":479703484},{"date":"2024-05-17","current":-4.890901,"twenty":-3.315512,"median":-2.789001,"eighty":-2.587423,"marketCap":512913725},{"date":"2024-05-24","current":-4.232917,"twenty":-3.42262,"median":-2.825105,"eighty":-2.589084,"marketCap":443910224},{"date":"2024-05-31","current":-2.709348,"twenty":-3.502687,"median":-2.828114,"eighty":-2.591336,"marketCap":284132063},{"date":"2024-06-07","current":-1.509494,"twenty":-3.425026,"median":-2.808133,"eighty":-2.567566,"marketCap":158302149},{"date":"2024-06-14","current":-1.189756,"twenty":-3.411789,"median":-2.77444,"eighty":-2.523039,"marketCap":124770876},{"date":"2024-06-21","current":-1.270227,"twenty":-3.387719,"median":-2.771913,"eighty":-2.479113,"marketCap":133209967},{"date":"2024-06-28","current":-1.305343,"twenty":-3.385312,"median":-2.760902,"eighty":-2.478086,"marketCap":136892614},{"date":"2024-07-05","current":-1.280783,"twenty":-3.370269,"median":-2.746866,"eighty":-2.439596,"marketCap":134316975},{"date":"2024-07-12","current":-1.189721,"twenty":-3.321529,"median":-2.746851,"eighty":-2.346733,"marketCap":124767186},{"date":"2024-07-15","current":-1.143556,"twenty":-3.318521,"median":-2.746851,"eighty":-2.337707,"marketCap":119925871},{"date":"2024-08-02","current":-1.185956,"twenty":-3.315512,"median":-2.746851,"eighty":-2.319655,"marketCap":124372353},{"date":"2024-08-09","current":-2.141328,"twenty":-3.309329,"median":-2.743872,"eighty":-2.223618,"marketCap":115770900},{"date":"2024-08-16","current":-2.095122,"twenty":-3.308652,"median":-2.737855,"eighty":-2.223379,"marketCap":113272752},{"date":"2024-08-23","current":-2.093757,"twenty":-3.306448,"median":-2.737855,"eighty":-2.172931,"marketCap":113198952},{"date":"2024-08-30","current":-1.876921,"twenty":-3.298764,"median":-2.732439,"eighty":-2.151172,"marketCap":101475737},{"date":"2024-09-06","current":-1.617565,"twenty":-3.282249,"median":-2.722812,"eighty":-2.140266,"marketCap":87453635},{"date":"2024-09-13","current":-1.337733,"twenty":-3.26098,"median":-2.722812,"eighty":-2.080202,"marketCap":72324525},{"date":"2024-09-20","current":-1.433285,"twenty":-3.25365,"median":-2.716795,"eighty":-2.039701,"marketCap":77490562},{"date":"2024-09-27","current":-1.344558,"twenty":-3.242468,"median":-2.712282,"eighty":-1.920165,"marketCap":72693527},{"date":"2024-10-04","current":-1.365033,"twenty":-3.230617,"median":-2.707769,"eighty":-1.702654,"marketCap":73800536},{"date":"2024-10-11","current":-1.262656,"twenty":-3.227058,"median":-2.691673,"eighty":-1.524742,"marketCap":68265495},{"date":"2024-10-18","current":-1.330908,"twenty":-3.219825,"median":-2.671304,"eighty":-1.501537,"marketCap":71955522},{"date":"2024-10-25","current":-1.42646,"twenty":-3.208688,"median":-2.646941,"eighty":-1.46692,"marketCap":77121560},{"date":"2024-10-31","current":-1.392334,"twenty":-3.203096,"median":-2.632643,"eighty":-1.418422,"marketCap":75276546},{"date":"2024-11-08","current":-1.719942,"twenty":-3.196195,"median":-2.598856,"eighty":-1.41353,"marketCap":92988675},{"date":"2024-11-15","current":-2.23183,"twenty":-3.184516,"median":-2.588807,"eighty":-1.418422,"marketCap":120663876},{"date":"2024-11-22","current":-1.781369,"twenty":-3.177837,"median":-2.578397,"eighty":-1.427825,"marketCap":96309699},{"date":"2024-11-29","current":-1.522012,"twenty":-3.177115,"median":-2.554528,"eighty":-1.433285,"marketCap":82287597},{"date":"2024-12-06","current":-1.399159,"twenty":-3.177115,"median":-2.515217,"eighty":-1.433285,"marketCap":75645549},{"date":"2024-12-13","current":-1.501537,"twenty":-3.168089,"median":-2.479113,"eighty":-1.433285,"marketCap":81180589},{"date":"2024-12-20","current":-1.460586,"twenty":-3.168089,"median":-2.474357,"eighty":-1.433285,"marketCap":78966573},{"date":"2024-12-27","current":-1.501537,"twenty":-3.129579,"median":-2.443501,"eighty":-1.455126,"marketCap":81180589},{"date":"2025-01-03","current":-1.665341,"twenty":-3.092409,"median":-2.402624,"eighty":-1.460586,"marketCap":90036653},{"date":"2025-01-10","current":-1.371859,"twenty":-3.073999,"median":-2.361776,"eighty":-1.433285,"marketCap":74169538},{"date":"2025-01-17","current":-1.387898,"twenty":-3.071877,"median":-2.33169,"eighty":-1.410844,"marketCap":75036694},{"date":"2025-01-24","current":-1.399159,"twenty":-3.068804,"median":-2.301603,"eighty":-1.400524,"marketCap":75645549},{"date":"2025-01-31","current":-1.406053,"twenty":-3.068202,"median":-2.256345,"eighty":-1.399159,"marketCap":76018242},{"date":"2025-02-07","current":-1.419635,"twenty":-3.065796,"median":-2.23183,"eighty":-1.400524,"marketCap":76752557},{"date":"2025-02-14","current":-1.569789,"twenty":-3.057974,"median":-2.223379,"eighty":-1.399159,"marketCap":84870616},{"date":"2025-02-21","current":-1.487887,"twenty":-3.026684,"median":-2.192894,"eighty":-1.399159,"marketCap":80442584},{"date":"2025-02-28","current":-1.542488,"twenty":-3.01164,"median":-2.160441,"eighty":-1.405985,"marketCap":83394605},{"date":"2025-03-07","current":-1.515187,"twenty":-2.957485,"median":-2.151172,"eighty":-1.405985,"marketCap":81918594},{"date":"2025-03-14","current":-1.562963,"twenty":-2.953273,"median":-2.151172,"eighty":-1.405985,"marketCap":84501613},{"date":"2025-03-21","current":-1.508362,"twenty":-2.952186,"median":-2.140443,"eighty":-1.406053,"marketCap":81549592},{"date":"2025-03-28","current":-1.491299,"twenty":-2.930407,"median":-2.122627,"eighty":-1.409534,"marketCap":80627085},{"date":"2025-04-04","current":-1.399228,"twenty":-2.915364,"median":-2.09444,"eighty":-1.405985,"marketCap":75649239},{"date":"2025-04-11","current":-1.293233,"twenty":-2.906392,"median":-2.04755,"eighty":-1.399159,"marketCap":69918627},{"date":"2025-04-17","current":-1.303607,"twenty":-2.884687,"median":-2.040725,"eighty":-1.399159,"marketCap":70479511},{"date":"2025-04-25","current":-1.296782,"twenty":-2.876731,"median":-2.026222,"eighty":-1.391447,"marketCap":70110509},{"date":"2025-05-02","current":-1.365033,"twenty":-2.873814,"median":-1.986124,"eighty":-1.385509,"marketCap":73800536},{"date":"2025-05-09","current":-1.308999,"twenty":-2.863616,"median":-1.922445,"eighty":-1.372793,"marketCap":67896491},{"date":"2025-05-16","current":-1.323014,"twenty":-2.858802,"median":-1.84962,"eighty":-1.371859,"marketCap":68623426},{"date":"2025-05-23","current":-1.285807,"twenty":-2.838921,"median":-1.812653,"eighty":-1.365033,"marketCap":66693542},{"date":"2025-05-30","current":-1.419268,"twenty":-2.834101,"median":-1.771131,"eighty":-1.365033,"marketCap":73616032},{"date":"2025-06-06","current":-1.234301,"twenty":-2.834101,"median":-1.665341,"eighty":-1.364924,"marketCap":64021963},{"date":"2025-06-13","current":-1.13826,"twenty":-2.830509,"median":-1.627803,"eighty":-1.353431,"marketCap":59040427},{"date":"2025-06-20","current":-1.045777,"twenty":-2.82691,"median":-1.603915,"eighty":-1.351383,"marketCap":54243392},{"date":"2025-06-27","current":-1.102761,"twenty":-2.821155,"median":-1.590264,"eighty":-1.344563,"marketCap":57199103},{"date":"2025-07-03","current":-1.067119,"twenty":-2.81239,"median":-1.583439,"eighty":-1.344558,"marketCap":55350400},{"date":"2025-07-11","current":-1.074233,"twenty":-2.796222,"median":-1.577125,"eighty":-1.337733,"marketCap":55719403},{"date":"2025-07-18","current":-1.067119,"twenty":-2.775956,"median":-1.571973,"eighty":-1.330908,"marketCap":55350400},{"date":"2025-07-25","current":-1.045777,"twenty":-2.771913,"median":-1.569789,"eighty":-1.325447,"marketCap":54243392},{"date":"2025-08-01","current":-1.01732,"twenty":-2.771913,"median":-1.562963,"eighty":-1.323057,"marketCap":52767381},{"date":"2025-08-08","current":-1.10269,"twenty":-2.767508,"median":-1.559551,"eighty":-1.316114,"marketCap":57195413},{"date":"2025-08-15","current":-1.244972,"twenty":-2.749288,"median":-1.549313,"eighty":-1.30613,"marketCap":64575467},{"date":"2025-08-22","current":-1.202288,"twenty":-2.746875,"median":-1.539076,"eighty":-1.295173,"marketCap":62361451},{"date":"2025-08-29","current":-1.192043,"twenty":-2.746851,"median":-1.535663,"eighty":-1.283666,"marketCap":61830087},{"date":"2025-09-05","current":-1.252086,"twenty":-2.746851,"median":-1.528838,"eighty":-1.279903,"marketCap":64944469},{"date":"2025-09-12","current":-1.280543,"twenty":-2.746851,"median":-1.522012,"eighty":-1.266708,"marketCap":66420480},{"date":"2025-09-19","current":-1.252086,"twenty":-2.746851,"median":-1.522012,"eighty":-1.266708,"marketCap":64944469},{"date":"2025-09-26","current":-1.266315,"twenty":-2.746851,"median":-1.515255,"eighty":-1.266315,"marketCap":65682475},{"date":"2025-10-03","current":-1.262758,"twenty":-2.743872,"median":-1.509318,"eighty":-1.262758,"marketCap":65497973},{"date":"2025-10-10","current":-1.209402,"twenty":-2.743872,"median":-1.508362,"eighty":-1.259201,"marketCap":62730453},{"date":"2025-10-17","current":-1.145374,"twenty":-2.743872,"median":-1.501537,"eighty":-1.252086,"marketCap":59409429},{"date":"2025-10-24","current":-1.180945,"twenty":-2.737855,"median":-1.501537,"eighty":-1.244972,"marketCap":61254443},{"date":"2025-10-31","current":-0.988793,"twenty":-2.737855,"median":-1.501537,"eighty":-1.230744,"marketCap":51287681},{"date":"2025-11-07","current":-1.10269,"twenty":-2.737855,"median":-1.496418,"eighty":-1.209402,"marketCap":57195413},{"date":"2025-11-14","current":-1.074233,"twenty":-2.737855,"median":-1.487887,"eighty":-1.209402,"marketCap":55719403},{"date":"2025-11-21","current":-1.01732,"twenty":-2.737855,"median":-1.474236,"eighty":-1.202288,"marketCap":52767381},{"date":"2025-11-28","current":-1.131146,"twenty":-2.733522,"median":-1.470824,"eighty":-1.192015,"marketCap":58671424},{"date":"2025-12-05","current":-0.853695,"twenty":-2.724737,"median":-1.467411,"eighty":-1.188059,"marketCap":44280320},{"date":"2025-12-12","current":-0.910608,"twenty":-2.722812,"median":-1.463589,"eighty":-1.184813,"marketCap":47232341},{"date":"2025-12-19","current":-1.10269,"twenty":-2.722812,"median":-1.460586,"eighty":-1.176947,"marketCap":57195413},{"date":"2025-12-26","current":-1.088461,"twenty":-2.722812,"median":-1.446936,"eighty":-1.173831,"marketCap":56457408},{"date":"2026-01-02","current":-1.23024,"twenty":-2.722812,"median":-1.440611,"eighty":-1.173831,"marketCap":52398379},{"date":"2026-01-09","current":-1.273558,"twenty":-2.721608,"median":-1.433285,"eighty":-1.173831,"marketCap":54243392},{"date":"2026-01-16","current":-1.455495,"twenty":-2.7186,"median":-1.433285,"eighty":-1.174372,"marketCap":61992448},{"date":"2026-01-23","current":-1.767387,"twenty":-2.716494,"median":-1.433285,"eighty":-1.175624,"marketCap":75276544},{"date":"2026-01-30","current":-5.657371,"twenty":-2.722812,"median":-1.443774,"eighty":-1.178099,"marketCap":240958743},{"date":"2026-02-06","current":-8.784953,"twenty":-2.730514,"median":-1.460586,"eighty":-1.180945,"marketCap":374168707},{"date":"2026-02-13","current":-8.360433,"twenty":-2.737855,"median":-1.460586,"eighty":-1.180945,"marketCap":356087576},{"date":"2026-02-20","current":-8.54237,"twenty":-2.743872,"median":-1.467001,"eighty":-1.180945,"marketCap":363836632},{"date":"2026-02-27","current":-7.961905,"twenty":-2.746851,"median":-1.467411,"eighty":-1.18578,"marketCap":339113453},{"date":"2026-03-06","current":-8.005223,"twenty":-2.74989,"median":-1.474236,"eighty":-1.18578,"marketCap":340958467},{"date":"2026-03-13","current":-7.242821,"twenty":-2.772372,"median":-1.481061,"eighty":-1.185956,"marketCap":308486232},{"date":"2026-03-20","current":-6.376455,"twenty":-2.825105,"median":-1.491299,"eighty":-1.188059,"marketCap":271585965},{"date":"2026-03-27","current":-5.847971,"twenty":-2.834101,"median":-1.501537,"eighty":-1.188059,"marketCap":249076802},{"date":"2026-04-02","current":-6.844293,"twenty":-2.873814,"median":-1.501537,"eighty":-1.189389,"marketCap":291512109},{"date":"2026-04-10","current":-10.396394,"twenty":-2.918373,"median":-1.501537,"eighty":-1.189749,"marketCap":442803204},{"date":"2026-04-17","current":-15.413298,"twenty":-2.967246,"median":-1.501537,"eighty":-1.191472,"marketCap":547603655},{"date":"2026-04-24","current":-16.786872,"twenty":-3.065796,"median":-1.508362,"eighty":-1.192015,"marketCap":596403980},{"date":"2026-05-01","current":-16.066309,"twenty":-3.07395,"median":-1.509494,"eighty":-1.194547,"marketCap":570803810},{"date":"2026-05-08","current":-15.424557,"twenty":-3.168089,"median":-1.515358,"eighty":-1.195503,"marketCap":548003657},{"date":"2026-05-15","current":-15.604698,"twenty":-3.179643,"median":-1.522012,"eighty":-1.200947,"marketCap":554403700},{"date":"2026-05-22","current":-13.015174,"twenty":-3.214398,"median":-1.525425,"eighty":-1.202288,"marketCap":462403086},{"date":"2026-05-29","current":-12.722445,"twenty":-3.239041,"median":-1.53225,"eighty":-1.202288,"marketCap":452003017},{"date":"2026-06-05","current":-12.384681,"twenty":-3.298764,"median":-1.535663,"eighty":-1.202288,"marketCap":440002937},{"date":"2026-06-12","current":-11.483977,"twenty":-3.315512,"median":-1.542488,"eighty":-1.202288,"marketCap":408002723},{"date":"2026-06-18","current":-11.551529,"twenty":-3.405771,"median":-1.552725,"eighty":-1.205134,"marketCap":410402739},{"date":"2026-06-26","current":-11.438941,"twenty":-3.677615,"median":-1.559459,"eighty":-1.209402,"marketCap":406402712},{"date":"2026-07-02","current":-11.934329,"twenty":-3.93219,"median":-1.562963,"eighty":-1.209402,"marketCap":424002830},{"date":"2026-07-10","current":-12.024399,"twenty":-4.46022,"median":-1.566376,"eighty":-1.209402,"marketCap":427202851},{"date":"2026-07-17","current":-12.778739,"twenty":-4.549441,"median":-1.569789,"eighty":-1.209402,"marketCap":454003030},{"date":"2026-07-24","current":-14.884134,"twenty":-4.579854,"median":-1.574294,"eighty":-1.210104,"marketCap":528803529},{"date":"2026-07-31","current":-14.636441,"twenty":-4.736082,"median":-1.577125,"eighty":-1.212913,"marketCap":520003471},{"date":"2026-08-07","current":-15.58218,"twenty":-4.838122,"median":-1.583439,"eighty":-1.22363,"marketCap":553603695},{"date":"2026-08-14","current":-14.478818,"twenty":-4.897939,"median":-1.590264,"eighty":-1.22363,"marketCap":514403433},{"date":"2026-08-21","current":-39.217883,"twenty":-5.596725,"median":-1.602777,"eighty":-1.23024,"marketCap":883539695},{"date":"2026-08-28","current":-40.932951,"twenty":-5.995254,"median":-1.614152,"eighty":-1.230744,"marketCap":922178457},{"date":"2026-09-04","current":-42.162083,"twenty":-6.376455,"median":-1.663764,"eighty":-1.230744,"marketCap":949869570},{"date":"2026-09-08","current":-42.905279,"twenty":-6.404178,"median":-1.664553,"eighty":-1.230744,"marketCap":966613034}],"updateTime":1789027307007},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665270943","title":"Adlai Nortye Doses First Patient in Phase I Trial for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665270943","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665270943?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:53","pubTimestamp":1788868406,"startTime":"0","endTime":"0","summary":"Adlai Nortye  has dosed the first patient in Australia in a global Phase I trial of AN4035 as a potential treatment for CEACAM5-enriched, RAS-addicted solid tumors, the company said Tuesday.The company also received a \"Study-May-Proceed\" letter from the US Food and Drug Administration on its investigational new drug application for AN4035, clearing the way to expand the trial to the US, the company said.The Phase I trial will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of AN4035 as both a monotherapy and in combination with cetuximab, the company said.Shares of the company were up 1.3% in recent premarket trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ALN","LU2133065610.SGD","IE00BZ199S13.USD","ANL","BK7104","ANL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327895","title":"Adlai Nortye doses first patient in AN4035 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327895","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327895?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:15","pubTimestamp":1788866121,"startTime":"0","endTime":"0","summary":"Adlai Nortye (ANL) announced that the first patient has been dosed with AN4035 in Australia, initiating the global Phase I trial in patients with C...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adlai-nortye-doses-first-patient-in-an4035-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adlai-nortye-doses-first-patient-in-an4035-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANL","BK4139","ALN","LU2133065610.SGD","IE00BZ199S13.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665229773","title":"Adlai Nortye Wins FDA IND Clearance for An4035 ADC Trial Expansion to US","url":"https://stock-news.laohu8.com/highlight/detail?id=2665229773","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665229773?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:03","pubTimestamp":1788865381,"startTime":"0","endTime":"0","summary":"Adlai Nortye wins FDA IND clearance for AN4035 ADC trial expansion to USAdlai Nortye received U.S. FDA IND clearance for AN4035, enabling its Phase I trial to expand into the U.S.First patient dosed i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL21sYH0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","LU2133065610.SGD","ANL","LU2210149790.SGD","LU2095319765.USD","BK4139","IE00B3QW5Z07.USD","LU0314104364.USD","IE00B64PRP62.GBP","LU2210150020.SGD","IE00BQXX3C00.GBP","SG9999014005.SGD","SG9999014039.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4585","IE00BKPKM429.USD","SG9999014013.SGD","BK4588","IE00BN0W2T93.GBP","BK4112","IE00BQXX3F31.USD","SG9999014021.USD","IE00BZ199S13.USD","IE00BQXX3D17.EUR","BCDF","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322646","title":"Adlai Nortye Group - to File Ind Application for An4035 with China Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322646","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322646?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA2XFHZR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANL","LU2133065610.SGD","BK4139","IE00BZ199S13.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322526","title":"Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA Ind Clearance for An4035, a First-in-Class Pan-Ras(on) Inhibitor-Based ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322526","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322526?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA2XFHZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BZ199S13.USD","LU2133065610.SGD","ANL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665032258","title":"Adlai Nortye assumed with a Buy at Lucid Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2665032258","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665032258?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:45","pubTimestamp":1788864325,"startTime":"0","endTime":"0","summary":"Lucid Capital assumed coverage of Adlai Nortye (ANL) with a Buy rating and price target of $49, up from $46. The firm believes AN9025, an oral pan-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adlai-nortye-assumed-with-a-buy-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adlai-nortye-assumed-with-a-buy-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2133065610.SGD","BK4596","BK4551","LCIZ","BK4555","ALN","IE00BZ199S13.USD","LCID","BK4139","BK4099","ANL","LCDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664135884","title":"Adlai Nortye's KRAS Opportunity Further Validated by GSK-Hutchmed Deal, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664135884","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664135884?lang=en_us&edition=fundamental","pubTime":"2026-09-04 23:09","pubTimestamp":1788534579,"startTime":"0","endTime":"0","summary":"Adlai Nortye  stands to benefit from the GSK -Hutchmed  deal, which validates growing interest in targeted KRAS therapies, Oppenheimer said in a note emailed Friday.Hutchmed said Thursday its unit licensed rights to GSK to develop and commercialize experimental cancer treatment HMPL-A830 outside Greater China.HMPL-A830 is an EGFR-targeted antibody-drug conjugate carrying a KRAS inhibitor payload. The deal highlights increasing interest in targeted approaches that aim to improve the therapeutic index of RAS-pathway inhibition, Oppenheimer analysts said.Adlai Nortye's approach is differentiated, with AN9025 already in the clinic and data expected in H1 2027. AN4035 uses a pan-RAS inhibitor payload with a CEACAM5-targeting antibody, which could provide advantages in breadth, durability, and target selection, the analysts added.The deal should improve \"investor awareness of comparable RAS-focused platforms and reinforce the strategic value embedded within Adlai Nortye's differentiated RAS ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1720051108.HKD","ONX","BK4139","LU1854104046.USD","BK4532","LU1978683503.SGD","LU1983260115.SGD","LU2357305700.SGD","LU1861219969.SGD","BK4007","ON","ALN","GSK","LU0124384867.USD","LU0724618433.USD","BK4605","BK4588","BK4512","BK4141","LU1861214812.USD","IE00BZ199S13.USD","LU1861215975.USD","ONG","LU1861220033.SGD","GSK.UK","BK4531","HCM","IE00BD6J9T35.USD","LU2133065610.SGD","BK4585","BK7104","LU1720051017.SGD","LU2360107325.USD","ANL","LU1829250122.USD","GSKH","LU1548497426.USD","IE00BFMHRM44.USD","LU1854103824.USD","LU2298322129.HKD","LU0348723411.USD","ANL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662004867","title":"Oppenheimer Sticks to Their Buy Rating for Adlai Nortye Ltd. Sponsored ADR (ANL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662004867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662004867?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:55","pubTimestamp":1787835325,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Jay Olson reiterated a Buy rating on Adlai Nortye Ltd. Sponsored ADR today and set a price target of $32.00. Olson covers the H...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-their-buy-rating-for-adlai-nortye-ltd-sponsored-adr-anl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-their-buy-rating-for-adlai-nortye-ltd-sponsored-adr-anl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARMH","APIE","SAPH","ALN","DIVL","AADR","ANL","DINT","CVY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662248477","title":"Major Insider Move Shakes Up Adlai Nortye’s Market Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2662248477","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662248477?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:13","pubTimestamp":1787796782,"startTime":"0","endTime":"0","summary":"New insider activity at Adlai Nortye Ltd. Sponsored ADR ( ($ANL) ) has taken place on August 26, 2026. Adlai Nortye Ltd. Sponsored ADR has seen ins...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-shakes-up-adlai-nortyes-market-narrative-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-shakes-up-adlai-nortyes-market-narrative-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2133065610.SGD","IE00BZ199S13.USD","ALN","DIVL","ARMH","APIE","SAPH","BK4139","CVY","ANL","AADR","DINT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740712","title":"Adlai Nortye Calls September Extraordinary Meeting to Authorize Major Share Issuance and Board Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740712","media":"TIPRANKS","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662740712?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:27","pubTimestamp":1787750843,"startTime":"0","endTime":"0","summary":"Adlai Nortye Ltd. Sponsored ADR ( ($ANL) ) has issued an update. Adlai Nortye Group Ltd. has called an Extraordinary General Meeting of shareholder...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adlai-nortye-calls-september-extraordinary-meeting-to-authorize-major-share-issuance-and-board-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adlai-nortye-calls-september-extraordinary-meeting-to-authorize-major-share-issuance-and-board-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVY","ANL","AADR","DIVL","LU2133065610.SGD","APIE","BK4139","SAPH","ARMH","ALN","DINT","IE00BZ199S13.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661295546","title":"Prince Harry, Elton John and other celebrities hit with initial $13 million bill after losing case against UK tabloid","url":"https://stock-news.laohu8.com/highlight/detail?id=2661295546","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661295546?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:13","pubTimestamp":1787318034,"startTime":"0","endTime":"0","summary":"Prince Harry and six other high-profile figures will have to make an initial payment of 9.5 million  toward the legal costs of a British tabloid newspaper after losing a high-stakes case against them last month, a UK High Court judge ruled Friday.The group – which also included Elton John and his husband, David Furnish – lost a case against the publisher of the Daily Mail over allegations of unlawful information gathering for stories published between 1997 and 2015.This figure, which must be paid to Associated Newspapers Limited  by 4pm on August 28, is only an initial sum and not the full total the group will eventually pay, the court said in its ruling.This is a developing story and will be updated.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cnn_highlight","url":"https://edition.cnn.com/2026/08/21/media/prince-harry-elton-john-case-daily-mail-publisher-intl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2026/08/21/media/prince-harry-elton-john-case-daily-mail-publisher-intl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["BK4139","LU2133065610.SGD","IE00BZ199S13.USD","ANL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121302","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (ANL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121302","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121302?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:40","pubTimestamp":1786740009,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-us-physical-therapy-usph-and-adlai-nortye-ltd-sponsored-adr-anl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-us-physical-therapy-usph-and-adlai-nortye-ltd-sponsored-adr-anl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","LU0128526141.USD","BK4137","LABU","BK4581","AADR","BK4139","XLV","XBI","BK4585","ANL","BK4588","LU0029874061.USD","LU0012050646.USD","IE00BZ199S13.USD","LU2133065610.SGD","DIVL","ARMH","LU0106261612.USD","USPH","CVY","APIE","DINT","SAPH","HCSG","ALN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659414301","title":"Earnings Flash (ANL) Adlai Nortye Posts H1 Revenue $13.1M","url":"https://stock-news.laohu8.com/highlight/detail?id=2659414301","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659414301?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:05","pubTimestamp":1786705552,"startTime":"0","endTime":"0","summary":"Earnings Flash (ANL) Adlai Nortye Posts H1 Revenue $13.1M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANL","ANL.AU","ALN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143247","title":"Adlai Nortye FY26 H1 Net Loss Narrows 70.9% to Us$5.3 Million; Revenue Turns to Us$13.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143247","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659143247?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:01","pubTimestamp":1786705312,"startTime":"0","endTime":"0","summary":"Adlai Nortye FY26 H1 net loss narrows 70.9% to US$5.3 million; revenue turns to US$13.1 millionAdlai Nortye posted a 1H 2026 net loss of USD 5.34 million, narrowing 70.9% from a year earlier; loss per","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL8KH4ky:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4585","BK4588","IE00BN0W2T93.GBP","LU2133065610.SGD","002755","SG9999014021.USD","LU2210149790.SGD","SG9999014005.SGD","NDAQ","BK4139","LU2095319765.USD","LU0314104364.USD","IE00BZ199S13.USD","BK0239","IE00B64PRP62.GBP","BK0028","BCDF","IE00BKPKM429.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","SG9999014013.SGD","SG9999014039.USD","ANL","BK4112","LU2210150020.SGD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143403","title":"Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143403","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659143403?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUACG2YZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANL","IE00BZ199S13.USD","LU2133065610.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656557340","title":"Adlai Nortye Director Lars Erik Birgerson Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2656557340","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656557340?lang=en_us&edition=fundamental","pubTime":"2026-08-04 22:59","pubTimestamp":1785855544,"startTime":"0","endTime":"0","summary":"Adlai Nortye director Lars Erik Birgerson files initial beneficial ownership statementAdlai Nortye director Lars Erik Birgerson filed an initial ownership report showing 166,668 American Depositary Sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL6NqB7k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANL","IE00BZ199S13.USD","LU2133065610.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656760873","title":"Adlai Nortye Receives Ethics Approval to Begin Phase 1 Trial of Cancer Drug AN4035","url":"https://stock-news.laohu8.com/highlight/detail?id=2656760873","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656760873?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:11","pubTimestamp":1785759089,"startTime":"0","endTime":"0","summary":"Adlai Nortye  said it has submitted a clinical trial notification to Australia's Therapeutic Goods Administration and received approval from the Human Research Ethics Committee to begin a phase 1 trial of AN4035.The global trial will assess the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of AN4035, both as a monotherapy and in combination with cetuximab, in patients with CEACAM5-enriched, RAS-addicted solid tumors.AN4035 is a CEACAM5-targeting antibody-drug conjugate built around a pan-RAS inhibitor payload.The company expects to begin dosing patients in the second half of the year.Adlai Nortye also said it is filing investigational new drug applications for AN4035 with the US Food and Drug Administration and China's National Medical Products Administration.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0124384867.USD","LU1861220033.SGD","BK4141","LU1854104046.USD","LU2357305700.SGD","LU1978683503.SGD","ON","ANL.AU","LU1861214812.USD","ALN","LU1861215975.USD","BK4605","LU1983260115.SGD","ANL","IE00BZ199S13.USD","LU1548497426.USD","BK7104","IE00BFMHRM44.USD","LU1861219969.SGD","LU1854103824.USD","IE00BD6J9T35.USD","BK4585","LU2133065610.SGD","LU1720051017.SGD","LU2298322129.HKD","LU1720051108.HKD","LU2360107325.USD","BK4588","BK4139","BK4512","LU0348723411.USD","LU0724618433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656373985","title":"Adlai Nortye - in Process of Ind Submissions for An4035 to U.S. FDA and China Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2656373985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656373985?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:00","pubTimestamp":1785754800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA7RQ6TC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANL","LU2133065610.SGD","BK4139","IE00BZ199S13.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656373525","title":"Adlai Nortye Announces Clinical Trial Notification Submission and Hrec Approval for the Phase I Clinical Trial of Pan-Ras(on) Inhibitor ADC An4035 in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2656373525","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656373525?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:00","pubTimestamp":1785754800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA7RQ6TC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2133065610.SGD","BK4139","ANL","IE00BZ199S13.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654049878","title":"Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2654049878","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654049878?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:55","pubTimestamp":1785164125,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Boris Peaker has maintained their bullish stance on ANL stock, giving a Buy rating on July 16. Boris Peaker has given his Buy ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/adlai-nortye-initiated-with-buy-on-differentiated-ras-targeting-pipeline-adc-strategy-and-solid-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/adlai-nortye-initiated-with-buy-on-differentiated-ras-targeting-pipeline-adc-strategy-and-solid-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ199S13.USD","ADC","BK4231","ANL","LU2133065610.SGD","BK4080","ALN","BK4139","NETL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":51,"code":"91000000","status":"200"}]}}